BECTON, DICKINSON AND COMPANY Income (Loss) from Continuing Operations, Per Diluted Share
BECTON, DICKINSON AND COMPANY (BDX) reported Income (Loss) from Continuing Operations, Per Diluted Share of $1.64 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was $1.64, a 4.46% increase year-over-year.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was -$0.13, a 123.64% decline year-over-year.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was $1.57.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was $0.55.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for fiscal 2025 was $5.82, a 0.68% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for fiscal 2024 was $5.86, a 14.90% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for fiscal 2023 was $5.10, a 5.20% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY income (loss) from continuing operations, per diluted share for fiscal 2022 was $5.38, a 3.86% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.64 10-Q · filed 2026-08-06 | $2.58 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.13 10-Q · filed 2026-05-07 | $0.96 10-Q · filed 2026-05-07 | ||||||
| 2025-09-30 | $5.82 10-K · filed 2025-11-25 | |||||||
| 2025-06-30 | $1.57 10-Q · filed 2026-08-06 | $2.62 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | $0.55 10-Q · filed 2026-05-07 | $1.05 10-Q · filed 2026-05-07 | ||||||
| 2024-09-30 | $5.86 10-K · filed 2025-11-25 | |||||||
| 2023-09-30 | $5.10 10-K · filed 2025-11-25 | |||||||
| 2023-06-30 | $1.36 10-Q · filed 2023-08-03 | $4.60 10-Q · filed 2023-08-03 | ||||||
| 2023-03-31 | $1.53 10-Q · filed 2023-05-04 | $3.24 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | $1.70 10-Q · filed 2023-02-02 | |||||||
| 2022-09-30 | $5.38 10-K · filed 2024-11-27 | |||||||
| 2022-06-30 | $1.28 10-Q · filed 2023-08-03 | $4.45 10-Q · filed 2023-08-03 | ||||||
| 2022-03-31 | $1.28 10-Q · filed 2023-05-04 | $3.18 10-Q · filed 2023-05-04 | ||||||
| 2021-12-31 | $1.90 10-Q · filed 2023-02-02 | |||||||
| 2021-09-30 | $5.18 10-K · filed 2023-11-21 | |||||||
| 2021-06-30 | $1.32 10-Q · filed 2022-08-04 | $4.72 10-Q · filed 2022-08-04 | ||||||
| 2020-09-30 | $0.87 10-K · filed 2022-11-22 | |||||||
| 2015-09-30 | $3.35 10-K · filed 2015-11-25 | |||||||
| 2014-09-30 | $5.99 10-K · filed 2015-11-25 | |||||||
| 2014-06-30 | $1.65 10-Q · filed 2014-08-04 | $4.47 10-Q · filed 2014-08-04 | ||||||
| 2014-03-31 | $1.45 10-Q · filed 2014-05-05 | $2.82 10-Q · filed 2014-05-05 | ||||||
| 2013-12-31 | $1.37 10-Q · filed 2014-02-10 | |||||||
| 2013-09-30 | $4.67 10-K · filed 2015-11-25 | |||||||
| 2013-06-30 | $1.47 10-Q · filed 2014-08-04 | $4.21 10-Q · filed 2014-08-04 | ||||||
| 2013-03-31 | $1.39 10-Q · filed 2014-05-05 | $2.74 10-Q · filed 2014-05-05 | ||||||
| 2012-12-31 | $1.35 10-Q · filed 2014-02-10 | |||||||
| 2012-09-30 | $5.30 8-K · filed 2015-03-13 | |||||||
| 2012-06-30 | $1.52 10-Q · filed 2013-08-05 | $3.95 10-Q · filed 2013-08-05 | ||||||
| 2012-03-31 | $1.31 10-Q · filed 2013-05-09 | $1.38 10-Q · filed 2012-05-03 | $2.45 10-Q · filed 2013-05-09 | $2.59 10-Q · filed 2012-05-03 | ||||
| 2011-12-31 | $1.14 10-Q · filed 2013-02-07 | $1.21 10-Q · filed 2012-02-07 | ||||||
| 2011-09-30 | $5.31 10-K · filed 2013-11-27 | $5.59 10-K · filed 2011-11-23 | ||||||
| 2011-06-30 | $1.44 10-Q · filed 2012-08-06 | $1.51 10-Q · filed 2011-08-02 | $4.02 10-Q · filed 2012-08-06 | $4.23 10-Q · filed 2011-08-02 | ||||
| 2011-03-31 | $1.38 10-Q · filed 2012-05-03 | $2.72 10-Q · filed 2012-05-03 | ||||||
| 2010-12-31 | $1.35 10-Q · filed 2012-02-07 | |||||||
| 2010-09-30 | $4.64 10-K · filed 2012-11-21 | $4.90 10-K · filed 2010-11-24 | ||||||
| 2010-06-30 | $1.23 10-Q · filed 2011-08-02 | $1.29 10-Q · filed 2010-08-04 | $3.66 10-Q · filed 2011-08-02 | $3.81 10-Q · filed 2010-08-04 | ||||
| 2010-03-31 | $1.18 10-Q · filed 2011-05-04 | $1.24 10-Q · filed 2010-05-06 | $2.43 10-Q · filed 2011-05-04 | $2.53 10-Q · filed 2010-05-06 | ||||
| 2009-12-31 | $1.25 10-Q · filed 2011-02-08 | $1.30 10-Q · filed 2010-02-08 | ||||||
| 2009-09-30 | $4.73 10-K · filed 2011-11-23 | $4.92 10-K · filed 2009-11-25 | ||||||
| 2009-06-30 | $1.38 10-Q · filed 2010-08-04 | $3.67 10-Q · filed 2010-08-04 | ||||||
| 2009-03-31 | $1.05 10-Q · filed 2010-05-06 | $2.30 10-Q · filed 2010-05-06 | ||||||
| 2008-12-31 | $1.25 10-Q · filed 2010-02-08 | |||||||
| 2008-09-30 | $4.27 10-K · filed 2010-11-24 | $4.42 10-K · filed 2009-11-25 | ||||||
| 2008-06-30 | $1.18 10-Q · filed 2009-08-10 | $3.31 10-Q · filed 2009-08-10 | ||||||
| 2007-09-30 | $3.30 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |